Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Rhabdomyosarcoma 6Wilms Tumor 3Rhabdomyosarcoma, Embryonal 3Sarcoma 2Rhabdomyosarcoma, Alveolar 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Pleuropulmonary blastoma 1Hydatidiform Mole, Invasive 1Histiocytoma, Malignant Fibrous 1Gestational Trophoblastic Disease 1Dermatofibrosarcoma 1Choriocarcinoma 1Beckwith-Wiedemann Syndrome 1

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mesna 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Dactinomycin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Choriocarcinoma × Dactinomycin × 1 year × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡